Overview
- An out-of-competition sample on January 26 detected the banned drug letrozole, leading to a provisional suspension announced on February 2.
- The NADO Italia appeals court on February 13 revoked the measure after recognizing fumus boni iuris, and the Italian federation said she will rejoin the team on Monday, February 16.
- Case files describe a likely household contamination linked to her mother’s prescribed letrozole for breast cancer, with traces possibly transferred via a shared Nutella spoon.
- Judges noted very low concentrations of the substance—about 1.1 ng/ml—and a prior negative test in late December 2025 as factors supporting temporary readmission.
- The merits case now proceeds to the national anti-doping tribunal, the prosecutor opposed the interim relief, and WADA called contamination plausible and does not plan an immediate challenge.